Due to the central role of the Raf/MEK/ERK signaling pathway in the initiation, maintenance, and metastasis of cancer, elements of this pathway (RAF, MEK, and ERK) are attractive targets for the development of potential cancer therapies. Here, MAPK1 is linked to cancer.